NewsRx

Search our medical news database

Mergers & Acquisitions

Vectura EGM shareholders approve recommended offer for Innovata plc

Published in Biotech Business Week, January 29th, 2007

The board of Vectura announced that, at the Vectura Extraordinary General Meeting held in relation to the recommended offer for Innovata by Vectura, that the proposal has received the overwhelming support of shareholders and, at the Vectura Extraordinary General Meeting, the resolution approving the acquisition was passed.

Implementation of the scheme remains conditional upon Innovata shareholder approval at the Innovata Extraordinary General Meeting and the Innovata Court Meeting, and satisfaction of the conditions set out in the admission document posted to Innovata shareholders.

Provided that the court sanctions the arrangement and confirms the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook